Vancouver, BC

Dear Doctor,

I wish to introduce to you a new bone grafting procedure which has been clinically applied successfully in parts of the human skeleton. This is the first time in human history that platelets have been successfully used to regenerate 100% vital new bone in the human skeleton without the addition of autogenous bone, allograft, xenograft or alloplast. This procedure ensures that autologous platelets and autologous thrombin constitute 80%-90% of the grafting package with the last 10%-20% being a carrier/filler (resorbable collagen sponge). Cerasorb or Eclipse (β-Tricalcium phosphate) can also be added as a carrier/filler with or without resorbable collagen sponge, thereby enhancing regenerative activity in the bony surgical site while providing resistance to soft tissue compressive forces. This package ensures that the osteogenic potential of every graft is maximized regardless of the osteogenic potential of the patient or bony site defect. This is particularly useful for health compromised patients who have greater difficulty healing due to conditions that negatively impact angiogenesis, osteoinduction, osteogenesis and resistance to infection.

This procedure has been tested and shown clinically to regenerate 100% viable vital new bone for a cross-section of patients involving extraction sockets, sinus lifts, alveolar ridge augmentation, cystic and other periapical bony defect without the addition of autogenous bone, allograft, xenograft or alloplast. The research indicates that as hcPRP concentration increases there is increased bone density, regeneration of vital new bone and resorption of graft material. This procedure has broader clinical applications in other parts of the human skeleton including Plastic Surgery, Dermatology, Orthopaedics, Sports Medicine, Spine Surgery, Neurosurgery, Podiatry, Open and Closed Joint Therapy and Orofacial Rejuvenation. The invented procedures for the production and activation of hcPRP have patent pending in USA, Canada and the European Union. The latest article has been published in "Implant Dentistry" June 2009. To view this publication go to www.implantdent.org.

The dense sticky gel that activated hcPRP forms confines all components of the grafting package to the surgical site, thereby preventing granule and liquid migration to ectopic sites while promoting healing and minimizing inflammation, pain and negative immunological responses.

These procedures and more are taught and practiced with hands-on experience in Dr. Smith's hcPRP Autografting Seminars. These seminars are offered in Metro Vancouver, B.C., Canada. You can initially register for these seminars on this website at register now.

Dr. Astley E. Smith and the Global Autografting Team

"you will never be rejected by your own body"

Vancouver, B.C Canada 2010 Winter Olympics